Insider Selling: LifeStance Health Group, Inc. (NASDAQ:LFST) Insider Sells 12,965 Shares of Stock

LifeStance Health Group, Inc. (NASDAQ:LFST) insider Danish J. Qureshi sold 12,965 shares of the company’s stock in a transaction on Monday, April 1st. The stock was sold at an average price of $5.93, for a total value of $76,882.45. Following the transaction, the insider now directly owns 4,911,050 shares in the company, valued at approximately $29,122,526.50. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

LifeStance Health Group Stock Performance

Shares of LifeStance Health Group stock opened at $5.71 on Friday. The firm has a fifty day moving average of $6.51 and a two-hundred day moving average of $6.54. LifeStance Health Group, Inc. has a 52 week low of $4.74 and a 52 week high of $9.59. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.20.

LifeStance Health Group (NASDAQ:LFST) last released its quarterly earnings data on Wednesday, February 28th. The company reported ($0.12) EPS for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.03). LifeStance Health Group had a negative net margin of 17.64% and a negative return on equity of 12.66%. The firm had revenue of $280.60 million during the quarter, compared to the consensus estimate of $263.14 million. As a group, equities research analysts forecast that LifeStance Health Group, Inc. will post -0.3 earnings per share for the current year.

Institutional Trading of LifeStance Health Group

Large investors have recently made changes to their positions in the company. Jennison Associates LLC increased its position in shares of LifeStance Health Group by 35.4% in the 3rd quarter. Jennison Associates LLC now owns 2,046,358 shares of the company’s stock valued at $14,058,000 after buying an additional 535,358 shares in the last quarter. FMR LLC increased its position in shares of LifeStance Health Group by 6.7% in the 3rd quarter. FMR LLC now owns 28,178,666 shares of the company’s stock valued at $193,587,000 after buying an additional 1,758,427 shares in the last quarter. SG Americas Securities LLC bought a new stake in shares of LifeStance Health Group in the 3rd quarter valued at $206,000. Principal Financial Group Inc. increased its position in shares of LifeStance Health Group by 4.5% in the 3rd quarter. Principal Financial Group Inc. now owns 3,895,887 shares of the company’s stock valued at $26,765,000 after buying an additional 168,091 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale bought a new stake in shares of LifeStance Health Group in the 3rd quarter valued at $34,000. Institutional investors own 85.50% of the company’s stock.

Analysts Set New Price Targets

LFST has been the subject of several recent research reports. The Goldman Sachs Group upped their target price on shares of LifeStance Health Group from $8.00 to $9.00 and gave the company a “neutral” rating in a research report on Monday, March 4th. Jefferies Financial Group upped their target price on shares of LifeStance Health Group from $8.00 to $9.00 and gave the company a “buy” rating in a research report on Wednesday, March 6th. Finally, Barclays upped their target price on shares of LifeStance Health Group from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Thursday, February 29th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, LifeStance Health Group has a consensus rating of “Hold” and an average target price of $8.60.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.